Arnold J.  Levine net worth and biography

Arnold Levine Biography and Net Worth

Director of PMV Pharmaceuticals
Arnold J. Levine is currently a Professor Emeritus at The Simons Center for Systems Biology at the Institute for Advanced Study in Princeton, and a joint Professor in the Pediatrics and Biochemistry Departments at the Cancer Institute of New Jersey. He received his B.A. in Biology from Harpur College, SUNY and his Ph.D. from the University of Pennsylvania.

He trained as a Postdoctoral Fellow at California Institute of Technology in the laboratory of Robert Sinsheimer. Dr. Levine is a widely acclaimed leader in cancer research. In 1979, Dr. Levine and others discovered the p53 tumor suppressor protein, a molecule that inhibits tumor development. He established the Simons Center for Systems Biology at the Institute for Advanced Study, which concentrates on research at the interface of molecular biology and the physical sciences: on genetics and genomics, polymorphisms and molecular aspects of evolution, signal transduction pathways and networks, stress responses, and pharmacogenomics in cancer biology. Dr. Levine helped shape U.S. science priorities as chairman of an influential 1996 review panel on federal AIDS research funding. He also chaired the National Cancer Advisory Board, which advises the National Academy of Sciences and its Institute of Medicine on cancer policy. He was elected to the National Academy of Sciences in 1991 and to its Institute of Medicine in 1995. In April 2001, Levine received the first Albany Medical Center Prize in Medicine and Biomedical Research, the largest annual prize in science or medicine offered in the United States. In 1968 Dr. Levine joined Princeton University as an Assistant Professor, becoming a Professor of biochemistry in 1976. In 1979, he moved to the SUNY Stony Brook School of Medicine to Chair the Department of Microbiology. He returned to Princeton in 1984. Between 1984 and 1996, he presided over a major expansion of Princeton’s life sciences programs as Chairman of the Department of Molecular Biology. From 1998 to 2002, Dr. Levine was President of The Rockefeller University.

What is Arnold J. Levine's net worth?

The estimated net worth of Arnold J. Levine is at least $576,020.61 as of June 21st, 2021. Dr. Levine owns 420,453 shares of PMV Pharmaceuticals stock worth more than $576,021 as of January 21st. This net worth approximation does not reflect any other investments that Dr. Levine may own. Additionally, Dr. Levine receives a salary of $140,000.00 as Director at PMV Pharmaceuticals. Learn More about Arnold J. Levine's net worth.

How old is Arnold J. Levine?

Dr. Levine is currently 84 years old. There are 5 older executives and no younger executives at PMV Pharmaceuticals. Learn More on Arnold J. Levine's age.

What is Arnold J. Levine's salary?

As the Director of PMV Pharmaceuticals, Inc., Dr. Levine earns $140,000.00 per year. There are 2 executives that earn more than Dr. Levine. The highest earning executive at PMV Pharmaceuticals is Dr. David H. Mack Ph.D., Co-Founder, CEO, President & Director, who commands a salary of $881,080.00 per year. Learn More on Arnold J. Levine's salary.

How do I contact Arnold J. Levine?

The corporate mailing address for Dr. Levine and other PMV Pharmaceuticals executives is , , . PMV Pharmaceuticals can also be reached via phone at 609-642-6670 and via email at investors@pmvpharma.com. Learn More on Arnold J. Levine's contact information.

Has Arnold J. Levine been buying or selling shares of PMV Pharmaceuticals?

Arnold J. Levine has not been actively trading shares of PMV Pharmaceuticals during the last ninety days. Most recently, Arnold J. Levine sold 3,500 shares of the business's stock in a transaction on Wednesday, September 22nd. The shares were sold at an average price of $30.00, for a transaction totalling $105,000.00. Learn More on Arnold J. Levine's trading history.

Who are PMV Pharmaceuticals' active insiders?

PMV Pharmaceuticals' insider roster includes Leila Alland (Insider), Richard Heyman (Director), Winston Kung (CFO), Arnold Levine (Director), David Mack (CEO), and Thilo Schroeder (Director). Learn More on PMV Pharmaceuticals' active insiders.

Are insiders buying or selling shares of PMV Pharmaceuticals?

During the last twelve months, insiders at the sold shares 2 times. They sold a total of 10,109 shares worth more than $15,163.50. The most recent insider tranaction occured on September, 11th when insider Deepika Jalota sold 7,218 shares worth more than $10,827.00. Insiders at PMV Pharmaceuticals own 7.6% of the company. Learn More about insider trades at PMV Pharmaceuticals.

Information on this page was last updated on 9/11/2024.

Arnold J. Levine Insider Trading History at PMV Pharmaceuticals

See Full Table

Arnold J. Levine Buying and Selling Activity at PMV Pharmaceuticals

This chart shows Arnold J Levine's buying and selling at PMV Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1$0Total Insider BuyingTotal Insider Selling

PMV Pharmaceuticals Company Overview

PMV Pharmaceuticals logo
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.
Read More

Today's Range

Now: $1.37
Low: $1.36
High: $1.40

50 Day Range

MA: $1.54
Low: $1.35
High: $1.69

2 Week Range

Now: $1.37
Low: $1.32
High: $2.26

Volume

59,171 shs

Average Volume

131,073 shs

Market Capitalization

$70.90 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.46